FDA Inspection 1231122 — Coriell Institue for Medical Research
The FDA completed an inspection of Coriell Institue for Medical Research on February 12, 2024 in Camden, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 12, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Camden, NJ (United States)